Format

Send to

Choose Destination
Int J Mol Sci. 2018 Sep 13;19(9). pii: E2752. doi: 10.3390/ijms19092752.

Ascorbic Acid in Colon Cancer: From the Basic to the Clinical Applications.

Author information

1
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. ije03@mail.aub.edu.
2
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. rb62@aub.edu.lb.
3
Department of Anatomy, Cell Biology and Physiology, American University of Beirut, Beirut 1107 2020, Lebanon. rn03@aub.edu.lb.
4
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. dm25@aub.edu.lb.
5
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. st29@aub.edu.lb.
6
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. fjn00@mail.aub.edu.
7
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. he53@aub.edu.lb.
8
Department of Internal Medicine-Division of Hematology-Oncology, American University of Beirut Medical Center, Riad El Solh, Beirut 1107 2020, Lebanon. as04@aub.edu.lb.

Abstract

Given the safety and potential benefits of intravenous ascorbic acid (AA) administration in cancer patients, there is merit in further exploring this therapeutic concept. In this review, we discuss the potential benefits of intravenous AA administration on colorectal cancer and we specifically focus on its effect on glycolysis in mutant and wild type RAS. We perform a PubMed and Ovid MEDLINE search using ascorbic acid, intravenous vitamin C, KRAS mutation, BRAF mutation and colorectal cancer (CRC) as keywords. At the cellular level, colorectal cancer cells undergo a metabolic shift called the Warburg effect to allow for more glucose absorption and utilization of glycolysis. This shift also allows AA to enter which leads to a disruption in the Warburg effect and a shutdown of the downstream KRAS pathway in mutated KRAS colon cancer cells. At the clinical level, AA is associated with tumour regression in advanced disease and improved tolerability and side effects of standard therapy. Based on these findings, we conclude that further clinical trials are needed on a larger scale to examine the therapeutic benefits of AA in colon cancer.

KEYWORDS:

AA; CRC; cell lines; vitamin C

PMID:
30217071
PMCID:
PMC6164730
DOI:
10.3390/ijms19092752
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center